Skip to content
Company Analysis

Incannex Healthcare Inc. IXHL

A comprehensive view of key metrics, scores, and financial health for Incannex Healthcare Inc.

Overview of Incannex Healthcare Inc.

IXHL NCM
Healthcare Drug Manufacturers - Specialty & Generic Micro Cap
Incannex Healthcare Inc. (IXHL), is a Micro Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $3.25, about 0.0% overvalued vs fair value, +339.2% 1Y return, ranked 818/1110 in sector.
$3.25
5.52%
As of March 13, 2026
Previous close • Vol 90d: 587.5%
52-Week Range
Market Cap
$59.84M
Enterprise Value
$-8.90M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Incannex Healthcare Inc..

Top Beats

Quick Facts

Website https://www.incannex.com
HQ Sydney, NSW
Employees 12
Fiscal year Jun 30

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-6
$-6
$-6
Current: $3.25

Engine Room Money Flow™

Micro Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$86.0K
616.7%%
Gross Profit
$86.0K
378.7%%
R&D Expense
$10.7M
-16.6%%
Operating Income (EBIT)
$-48.3M
-162.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

R&D Intensity
12496.5%
Fair

High R&D intensity - heavy pipeline investment

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Incannex Healthcare Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
20
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
30
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 91% Coverage
Trade-Off Triangle Visualization A ternary plot showing IXHL's balance between Growth (44.6%), Profitability (13.8%), and Safety (41.6%). Growth 45% Safety 42% Profitability 14%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

46th percentile vs peers
46
Key Signals
Rev Growth YoY 6.17 98p EPS Growth YoY -19.2% 26p TSR -52.4% 34p Revenue CAGR 3Y -45.8% 3p
Strengths
  • Rev Growth Yoy in top 20% of peers (6.17, 98th percentile)
  • Gross Profit Margin in top 20% of peers (1.00, 97th percentile)
  • Quick Ratio in top 20% of peers (9.18, 95th percentile)
  • Strong liquidity position vs peers
Risks

No significant risks identified for this axis.

Profitability

14th percentile vs peers
14
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

43th percentile vs peers
43
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Incannex Healthcare Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-6.27
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info